• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Mirum Pharmaceuticals

Finish finish line
Pharma

Mirum's Ctexli scores FDA approval in rare metabolic disorder

The FDA on Friday gave the green light to Mirum’s Ctexli for the treatment of adults with the rare metabolic disorder cerebrotendinous xanthomatosis.
Fraiser Kansteiner Feb 21, 2025 3:30pm
Livmarli

Mirum gets 2nd indication for blockbuster hopeful Livmarli

Mar 13, 2024 6:20pm
Travere

Travere cuts 20% of workforce, aims to win full nod for Filspari

Dec 5, 2023 11:26am
Liver disease

Mirum ponies up $445M for 2 Travere liver disease drugs

Jul 18, 2023 8:00am
Ipsen

Ipsen pays $952M to acquire Albireo and liver disease med Bylvay

Jan 9, 2023 10:05am
Liver disease

Mirum gets a leg up on Albireo in pediatric liver disease

Oct 24, 2022 3:11pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings